Precision Treatment in ACS–Role of Assessing Fibrinolysis

Despite advancements in pharmacotherapy and interventional strategies, patients with acute coronary syndrome (ACS) remain at risk of recurrent thrombotic events. In addition to an enhanced tendency to thrombus formation, impairment in the ability to naturally dissolve or lyse a developing thrombus,...

Descripción completa

Detalles Bibliográficos
Autores principales: Gue, Ying X., Jeong, Young-Hoon, Farag, Mohamed, Spinthakis, Nikolaos, Gorog, Diana A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957496/
https://www.ncbi.nlm.nih.gov/pubmed/33804303
http://dx.doi.org/10.3390/jcm10050929

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957496/
https://www.ncbi.nlm.nih.gov/pubmed/33804303
http://dx.doi.org/10.3390/jcm10050929

Ejemplares similares